News Headlines Article

California stem cell agency adopts spending plan aimed at bringing cures to market
Sacramento Bee

California’s stem cell agency on Thursday charted a fresh, $890 million course that aims to make good on its unfulfilled promise to voters that it would produce stem cell treatments ready for wide-scale use on patients. The agency proposes to help fund 50 new clinical trials for stem cell therapies on top of the 15 it already has underway. Next year, it plans to crank up a $150 million partnership with private investors to turn research into cures.